What the emergency radiologist needs to know about treatment-related complications from conventional chemotherapy and newer molecular targeted agents

被引：11

作者：

Sona A. Chikarmane

Bharti Khurana

Katherine M. Krajewski

Atul B. Shinagare

Stephanie Howard

Aaron Sodickson

Jyothi Jagannathan

Nikhil Ramaiya

机构：

[1] Department of Emergency Radiology, Brigham and Women's Hospital, Boston, MA 02115

[2] Department of Imaging, Dana Farber Cancer Institute, Boston, MA 02115

来源：

Emergency Radiology | 2012年 / 19卷 / 6期

关键词：

Chemotherapy; Complications; Emergency; Molecular targeted therapy; Oncology;

D O I：

10.1007/s10140-012-1052-1

中图分类号：

学科分类号：

摘要：

Emergency departments (ED) are increasingly utilized by oncology patients for disease- and treatment-related issues. With the increased use of new molecular targeted therapy (MTT) and conventional chemotherapeutic regimens, oncology patients present with a range of adverse treatment effects, some of which reveal characteristic injury patterns and imaging appearances. Knowledge of these imaging findings is critically important for early detection and prompt management in oncology patients. In this article, we present a brief review of conventional chemotherapeutic and new MTT regimens as well as address adverse reactions that bring oncology patients to the ED. © Am Soc Emergency Radiol 2012.

引用

页码：535 / 546

页数：11

共 38 条

[1]

Skeel R.T., Handbook of Cancer Chemotherapy, (2003)

[2]

Adelberg D.E., Bishop M.R., Emergencies related to cancer chemotherapy and hematopoietic stem cell transplantation, Emerg Med Clin North Am, 27, pp. 311-331, (2009)

[3]

Glass J.P., Lee Y.Y., Bruner J., Fields W.S., Treatment-related leukoencephalopathy, A Study of Three Cases and Literature Review. Medicine (Baltimore), 65, pp. 154-162, (1986)

[4]

Chu W.C., Lee V., Howard R.G., Roebuck D.J., Chik K.W., Li C.K., Imaging findings of paediatric oncology patients presenting with acute neurological symptoms, Clin Radiol, 58, pp. 589-603, (2003)

[5]

Agarwal A., Vijay K., Thamburaj K., Ouyang T., Transient leukoencephalopathy after intrathecal methotrexate mimicking stroke, Emerg Radiol, 18, pp. 345-347, (2011)

[6]

McKinney A.M., Short J., Truwit C.L., Et al., Posterior reversible encephalopathy syndrome: Incidence of atypical regions of involvement and imaging findings, AJR Am J Roentgenol, 189, pp. 904-912, (2007)

[7]

Hodnett P., Coyle J., O'Regan K., Maher M.M., Fanning N., PRES (posterior reversible encephalopathy syndrome), a rare complication of tacrolimus therapy, Emerg Radiol, 16, pp. 493-496, (2009)

[8]

Torrisi J.M., Schwartz L.H., Gollub M.J., Ginsberg M.S., Bosl G.J., Hricak H., CT findings of chemotherapy-induced toxicity: What radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicity, Radiology, 258, pp. 41-56, (2011)

[9]

Duran I., Siu L.L., Oza A.M., Et al., Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus, Eur J Cancer, 42, pp. 1875-1880, (2006)

[10]

Van Glabbeke M., Verweij J., Casali P.G., Et al., Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISGAGITG), Eur J Cancer, 42, pp. 2277-2285, (2006)

← 1 2 3 4 →